Netherlands· NL-2a8761b40b9e
Pamorelin 11,25 mg poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifte
A triptorelin product containing triptorelinepamoaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Triptorelin is registered in 11 of 19 countries.
Countries holding a registration under ATC L02AE04 (triptorelin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Triptorelin · ATC L02AE04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of triptorelin costs, country by country.
Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Triptorelin · price per daily dose (0.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.91
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TRIPTORELINEPAMOAAT
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- L02AE04
- ATC class
- Triptorelin
- Defined daily dose
- 0.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129521//31138
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
321 interactions on record for triptorelin.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triptorelin · interactions on record
321 records
- 69 severe
- 249 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triptorelin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceDECAPEPTYL L.P. 11,25 mg, poudre et solvant pour suspension injectable (IM ou SC) forme à libération prolongée sur 3 moisBB FARMA (ITALIE)
- IrelandDecapeptyl 3-month, 11.25 mg powder and solvent for suspension for injectionIMED Healthcare Ltd.,
- United KingdomDecapeptyl SR 11.25mg powder and solvent for suspension for injection vialsDE Pharmaceuticals
- SwitzerlandDecapeptyl
- PolandDecapeptyl 0,1 mgFerring GmbH
- SwedenPamorelin 11,25 mg Pulver och vätska till injektionsvätska, depotsuspensionInstitut Produits Synthèse (IPSEN) AB
- SpainDECAPEPTYL DIARIO 0,1 mg polvo y disolvente para solución inyectableIpsen Pharma S.A.U.
- ItalyDECAPEPTYL*1 flaconcino IM 11,25 mg + 1 fiala solv 2 ml + 1 siringaIPSEN SpA
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Pamorelin La, Salvacyl
- Belgium · Decapeptyl, Decapeptyl Sustained Release
- Bulgaria · Диферелин, Диферелин S.R.
- Cyprus · Arvekap
- Czechia · Diphereline, Diphereline S.R.
- Germany · Pamorelin La, Salvacyl
- Denmark · Pamorelin
- Estonia · Diphereline
- Spain · Decapeptyl Diario, Decapeptyl Mensual
- Finland · Pamorelin
- France · Decapeptyl (S.C.), Decapeptyl L.P. (I.M.) Sur 28 Jours
- United Kingdom (Northern Ireland) · Gonapeptyl Depot
- Greece · Arvekap, Salvapar
- Croatia · Decapeptyl Cr
- Hungary · Diphereline, Diphereline Sr
- Ireland · Decapeptyl 3-Month, Decapeptyl 6-Month
- Italy · Decapeptyl, Gonapeptyl Depot
- Lithuania · Diphereline
- Luxembourg · Decapeptyl, Decapeptyl Sustained Release
- Latvia · Diphereline
- Norway · Pamorelin
- Poland · Diphereline, Diphereline Sr
- Portugal · Decapeptyl, Decapeptyl Lp
- Romania · Diphereline, Diphereline Pr
- Sweden · Pamorelin
- Slovenia · Diphereline, Pamorelin
- Slovakia · Diphereline, Diphereline S.R.
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f966e88d-6b16-4fb9-83c1-0be6bf2d0a26 GET /v1/drugs/f966e88d-6b16-4fb9-83c1-0be6bf2d0a26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte",
"route": "Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31138_smpc.pdf",
"strength": null,
"atc_label": "Triptorelin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129521",
"excipients": [
"CARMELLOSE NATRIUM (E 466)",
"MANNITOL (D-) (E 421)",
"MANNITOL (D-) (E 421)",
"MELKZUUR(D,L)-GLYCOLZUUR COPOLYMEER",
"POLYSORBAAT 80 (E 433)",
"WATER VOOR INJECTIE"
],
"substances": [
"TRIPTORELINEPAMOAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129521.pdf",
"authorised_at": "2023/10/11",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "129521//31138",
"additional_monitoring": "N"
}See everything about triptorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.